These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 24409297)

  • 1. A cost effectiveness analysis of salt reduction policies to reduce coronary heart disease in four Eastern Mediterranean countries.
    Mason H; Shoaibi A; Ghandour R; O'Flaherty M; Capewell S; Khatib R; Jabr S; Unal B; Sözmen K; Arfa C; Aissi W; Ben Romdhane H; Fouad F; Al-Ali R; Husseini A;
    PLoS One; 2014; 9(1):e84445. PubMed ID: 24409297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An economic evaluation of salt reduction policies to reduce coronary heart disease in England: a policy modeling study.
    Collins M; Mason H; O'Flaherty M; Guzman-Castillo M; Critchley J; Capewell S
    Value Health; 2014 Jul; 17(5):517-24. PubMed ID: 25128044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of salt reduction policies to reduce coronary heart disease in Syria, 2010-2020.
    Wilcox ML; Mason H; Fouad FM; Rastam S; al Ali R; Page TF; Capewell S; O'Flaherty M; Maziak W
    Int J Public Health; 2015 Jan; 60 Suppl 1():S23-30. PubMed ID: 24972676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of simulation models in health economic evaluation studies of dietary salt-reduction policies for cardiovascular disease prevention].
    Kato H; Ikeda N; Sugiyama T; Nomura M; Yoshita K; Nishi N
    Nihon Koshu Eisei Zasshi; 2021 Sep; 68(9):631-643. PubMed ID: 34261839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of trans fats policies to reduce socioeconomic inequalities in mortality from coronary heart disease in England: cost effectiveness modelling study.
    Allen K; Pearson-Stuttard J; Hooton W; Diggle P; Capewell S; O'Flaherty M
    BMJ; 2015 Sep; 351():h4583. PubMed ID: 26374614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The cost-utility ratio of reducing salt intake and its impact on the incidence of cardiovascular disease in Argentina].
    Ferrante D; Konfino J; Mejía R; Coxson P; Moran A; Goldman L; Pérez-Stable EJ
    Rev Panam Salud Publica; 2012 Oct; 32(4):274-80. PubMed ID: 23299288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010.
    Fidan D; Unal B; Critchley J; Capewell S
    QJM; 2007 May; 100(5):277-89. PubMed ID: 17449875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Health Equity and Effectiveness of Policy Options to Reduce Dietary Salt Intake in England: Policy Forecast.
    Gillespie DO; Allen K; Guzman-Castillo M; Bandosz P; Moreira P; McGill R; Anwar E; Lloyd-Williams F; Bromley H; Diggle PJ; Capewell S; O'Flaherty M
    PLoS One; 2015; 10(7):e0127927. PubMed ID: 26131981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eliminating artificial trans fatty acids in Argentina: estimated effects on the burden of coronary heart disease and costs.
    Rubinstein A; Elorriaga N; Garay OU; Poggio R; Caporale J; Matta MG; Augustovski F; Pichon-Riviere A; Mozaffarian D
    Bull World Health Organ; 2015 Sep; 93(9):614-22. PubMed ID: 26478625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salt intake reduction strategies in the Eastern Mediterranean Region.
    Al Jawaldeh A; Rafii B; Nasreddine L
    East Mediterr Health J; 2019 Feb; 24(12):1172-1180. PubMed ID: 30799557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Projected effect of dietary salt reductions on future cardiovascular disease.
    Bibbins-Domingo K; Chertow GM; Coxson PG; Moran A; Lightwood JM; Pletcher MJ; Goldman L
    N Engl J Med; 2010 Feb; 362(7):590-9. PubMed ID: 20089957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrasting cardiovascular mortality trends in Eastern Mediterranean populations: Contributions from risk factor changes and treatments.
    Critchley J; Capewell S; O'Flaherty M; Abu-Rmeileh N; Rastam S; Saidi O; Sözmen K; Shoaibi A; Husseini A; Fouad F; Ben Mansour N; Aissi W; Ben Romdhane H; Unal B; Bandosz P; Bennett K; Dherani M; Al Ali R; Maziak W; Arık H; Gerçeklioğlu G; Altun DU; Şimşek H; Doganay S; Demiral Y; Aslan Ö; Unwin N; Phillimore P; ; ; Achour N; Aissi W; Allani R; Arfa C; Abu-Kteish H; Abu-Rmeileh N; Al Ali R; Altun D; Ahmad B; Arık H; Aslan Ö; Beltaifa L; Ben Mansour N; Bennett K; Ben Romdhane H; Ben Salah N; Collins M; Critchley J; Capewell S; Dherani M; Demiral Y; Doganay S; Elias M; Ergör G; Fadhil I; Fouad F; Gerçeklioğlu G; Ghandour R; Göğen S; Husseini A; Jaber S; Kalaca S; Khatib R; Khatib R; Koudsie S; Kilic B; Lassoued O; Mason H; Maziak W; Mayaleh MA; Mikki N; Moukeh G; Flaherty MO; Phillimore P; Rastam S; Roglic G; Saidi O; Saatli G; Satman I; Shoaibi A; Şimşek H; Soulaiman N; Sözmen K; Tlili F; Unal B; Unwin N; Yardim N; Zaman S
    Int J Cardiol; 2016 Apr; 208():150-61. PubMed ID: 26878275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost and health consequences of reducing the population intake of salt.
    Selmer RM; Kristiansen IS; Haglerod A; Graff-Iversen S; Larsen HK; Meyer HE; Bonaa KH; Thelle DS
    J Epidemiol Community Health; 2000 Sep; 54(9):697-702. PubMed ID: 10942450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential benefits of healthy food and lifestyle policies for reducing coronary heart disease mortality in Turkish adults by 2025: a modelling study.
    Sahan C; Sozmen K; Unal B; O'Flaherty M; Critchley J
    BMJ Open; 2016 Jul; 6(7):e011217. PubMed ID: 27388358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review of dietary salt reduction policies: Evidence for an effectiveness hierarchy?
    Hyseni L; Elliot-Green A; Lloyd-Williams F; Kypridemos C; O'Flaherty M; McGill R; Orton L; Bromley H; Cappuccio FP; Capewell S
    PLoS One; 2017; 12(5):e0177535. PubMed ID: 28542317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health Impact and Cost-Effectiveness of Achieving the National Salt and Sugar Reduction Initiative Voluntary Sugar Reduction Targets in the United States: A Microsimulation Study.
    Shangguan S; Mozaffarian D; Sy S; Lee Y; Liu J; Wilde PE; Sharkey AL; Dowling EA; Marklund M; Abrahams-Gessel S; Gaziano TA; Micha R
    Circulation; 2021 Oct; 144(17):1362-1376. PubMed ID: 34445886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Process Evaluation and Costing of a Multifaceted Population-Wide Intervention to Reduce Salt Consumption in Fiji.
    Webster J; Pillay A; Suku A; Gohil P; Santos JA; Schultz J; Wate J; Trieu K; Hope S; Snowdon W; Moodie M; Jan S; Bell C
    Nutrients; 2018 Jan; 10(2):. PubMed ID: 29385758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing population salt intake worldwide: from evidence to implementation.
    He FJ; MacGregor GA
    Prog Cardiovasc Dis; 2010; 52(5):363-82. PubMed ID: 20226955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease and impoverishment averted due to a salt reduction policy in South Africa: an extended cost-effectiveness analysis.
    Watkins DA; Olson ZD; Verguet S; Nugent RA; Jamison DT
    Health Policy Plan; 2016 Feb; 31(1):75-82. PubMed ID: 25841771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease: effect of grain fortification and beyond.
    Tice JA; Ross E; Coxson PG; Rosenberg I; Weinstein MC; Hunink MG; Goldman PA; Williams L; Goldman L
    JAMA; 2001 Aug 22-29; 286(8):936-43. PubMed ID: 11509058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.